- Home
- Publications
- Publication Search
- Publication Details
Title
Targeted therapies and clinical trials in ovarian cancer
Authors
Keywords
-
Journal
ANNALS OF ONCOLOGY
Volume 24, Issue suppl 10, Pages x59-x63
Publisher
Oxford University Press (OUP)
Online
2013-11-21
DOI
10.1093/annonc/mdt473
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Low-grade serous carcinoma: New concepts and emerging therapies
- (2013) Ignacio Romero et al. GYNECOLOGIC ONCOLOGY
- Crizotinib versus Chemotherapy in Advanced ALK-Positive Lung Cancer
- (2013) Alice T. Shaw et al. NEW ENGLAND JOURNAL OF MEDICINE
- Efficacy of HER2-targeted therapy in metastatic breast cancer. Monoclonal antibodies and tyrosine kinase inhibitors
- (2012) Dorte L. Nielsen et al. BREAST
- Cancer statistics, 2012
- (2012) Rebecca Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- MEK and RAF inhibitors for BRAF-mutated cancers
- (2012) Sarah Belden et al. EXPERT REVIEWS IN MOLECULAR MEDICINE
- Molecular characterization of mucinous ovarian tumours supports a stratified treatment approach with HER2 targeting in 19% of carcinomas
- (2012) Michael S Anglesio et al. JOURNAL OF PATHOLOGY
- Selumetinib in women with recurrent low-grade serous carcinoma of the ovary or peritoneum: an open-label, single-arm, phase 2 study
- (2012) John Farley et al. LANCET ONCOLOGY
- Improved Survival with MEK Inhibition in BRAF-Mutated Melanoma
- (2012) Keith T. Flaherty et al. NEW ENGLAND JOURNAL OF MEDICINE
- Trastuzumab Emtansine for HER2-Positive Advanced Breast Cancer
- (2012) Sunil Verma et al. NEW ENGLAND JOURNAL OF MEDICINE
- EGFR-Mediated Reactivation of MAPK Signaling Contributes to Insensitivity of BRAF -Mutant Colorectal Cancers to RAF Inhibition with Vemurafenib
- (2012) Ryan B. Corcoran et al. Cancer Discovery
- Recent progress in the diagnosis and treatment of ovarian cancer
- (2011) Danijela Jelovac et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Genomic Analysis Reveals the Molecular Heterogeneity of Ovarian Clear Cell Carcinomas
- (2011) David S.P. Tan et al. CLINICAL CANCER RESEARCH
- Integrated genomic analyses of ovarian carcinoma
- (2011) D. Bell et al. NATURE
- Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation
- (2011) Paul B. Chapman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Identification of Novel Therapeutic Targets in Microdissected Clear Cell Ovarian Cancers
- (2011) Michael P. Stany et al. PLoS One
- The Origin and Pathogenesis of Epithelial Ovarian Cancer: A Proposed Unifying Theory
- (2010) Robert J. Kurman et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Kinase-Dead BRAF and Oncogenic RAS Cooperate to Drive Tumor Progression through CRAF
- (2010) Sonja J. Heidorn et al. CELL
- Trastuzumab in gastric cancer
- (2010) Alicia F.C. Okines et al. EUROPEAN JOURNAL OF CANCER
- Anaplastic Lymphoma Kinase Inhibition in Non–Small-Cell Lung Cancer
- (2010) Eunice L. Kwak et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effective Incorporation of Biomarkers into Phase II Trials
- (2009) L. M. McShane et al. CLINICAL CANCER RESEARCH
- Tiling Path Genomic Profiling of Grade 3 Invasive Ductal Breast Cancers
- (2009) R. Natrajan et al. CLINICAL CANCER RESEARCH
- PPM1D Is a Potential Therapeutic Target in Ovarian Clear Cell Carcinomas
- (2009) D. S.P. Tan et al. CLINICAL CANCER RESEARCH
- Combination chemotherapy of oxaliplatin and 5-fluorouracil may be an effective regimen for mucinous adenocarcinoma of the ovary: A potential treatment strategy
- (2008) Seiya Sato et al. CANCER SCIENCE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started